FDA Announces Submission of Blood Establishment Registration and Product Listing Form for OMB Review

Summary

The Food and Drug Administration (FDA) is requesting public comment on a proposed information collection related to blood establishment registration and product listing, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.